Standard Protocols for Checkpoint Inhibitor Delivery: Evaluation of Injectable Product Types in the Oncology Drugs Market
Immunotherapy has revolutionized the oncology landscape by harnessing the power of the body's own immune system to recognize and destroy cancer cells. Within this field, checkpoint inhibitors have emerged as a dominant therapeutic category, with numerous use cases across a broad range of cancer types. These agents work by blocking proteins that prevent immune cells from attacking the tumor,...
0 Comments 0 Shares 29 Views 0 Reviews